Crosslink Capital Amends Weave Communications Stake
Ticker: WEAV · Form: SC 13D/A · Filed: Dec 9, 2024 · CIK: 1609151
| Field | Detail |
|---|---|
| Company | Weave Communications, Inc. (WEAV) |
| Form Type | SC 13D/A |
| Filed Date | Dec 9, 2024 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.0 |
| Sentiment | neutral |
Sentiment: neutral
Topics: ownership-change, sec-filing, schedule-13d
Related Tickers: WEAV
TL;DR
Crosslink Capital just updated their Weave stake. Watch this one.
AI Summary
On December 5, 2024, Crosslink Capital, Inc. filed an amendment (Amendment No. 3) to its Schedule 13D regarding Weave Communications, Inc. The filing indicates a change in beneficial ownership of the common stock of Weave Communications, Inc. by Crosslink Capital Management, LLC, Crosslink Ventures VII Holdings, L.L.C., and Michael J. Stark.
Why It Matters
This filing signals a potential shift in significant ownership for Weave Communications, Inc., which could impact its stock price and strategic direction.
Risk Assessment
Risk Level: medium — Schedule 13D filings often indicate significant investor activity, which can lead to increased volatility.
Key Numbers
- 3 — Amendment Number (Indicates this is the third update to the filing.)
Key Players & Entities
- Crosslink Capital, Inc. (company) — Filing entity
- Weave Communications, Inc. (company) — Subject company
- Crosslink Capital Management, LLC (company) — Group member
- Crosslink Ventures VII Holdings, L.L.C. (company) — Group member
- Michael J. Stark (person) — Group member
- Maureen Offer (person) — Authorized contact
FAQ
What specific changes in beneficial ownership are detailed in this Amendment No. 3?
The filing is an amendment to a Schedule 13D, indicating a change in beneficial ownership, but the specific details of the change (e.g., percentage increase/decrease, number of shares) are not provided in the header information.
Who are the members of the filing group for Crosslink Capital, Inc.?
The group members are Crosslink Capital Management, LLC, Crosslink Ventures VII Holdings, L.L.C., and Michael J. Stark.
What is the CUSIP number for Weave Communications, Inc. common stock?
The CUSIP number for Weave Communications, Inc. common stock is 94724R108.
When was the event requiring this filing amendment?
The date of the event which requires filing of this statement is December 5, 2024.
What is the business address for Weave Communications, Inc.?
The business address for Weave Communications, Inc. is 1331 W Powell Way, Lehi, UT 84043.
Filing Stats: 1,379 words · 6 min read · ~5 pages · Grade level 7.5 · Accepted 2024-12-09 19:11:00
Key Financial Figures
- $0.0 — Inc. (Name of Issuer) Common stock, $0.0 001 par value per share (Title of Cla
Filing Documents
- tm2430562d1_sc13da.htm (SC 13D/A) — 82KB
- tm2430562d1_ex99-1.htm (EX-99.1) — 7KB
- 0001104659-24-126879.txt ( ) — 91KB
Interest in Securities of the Issuer
Item 5. Interest in Securities of the Issuer
of the Schedule 13D is hereby amended and
Item 5 of the Schedule 13D is hereby amended and restated in its entirety as follows: (a) See rows (11) and (13) of the cover pages of this Amendment for the aggregate number of shares of Stock and percentages of the shares of Stock beneficially owned by each Filer. Calculations of the percentage of the shares of Stock beneficially owned is based on 72,771,106 shares of Stock outstanding as of November 1, 2024, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the SEC on November 8, 2024. (b) See rows (7) through (10) on the cover pages of this Amendment for the number of shares of Stock as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition. (c) The Filers effected the following transactions in the Issuer’s Stock since the most recent amendment to this Schedule 13D: Name Transaction Date No. Shares Weighted Average Price ($) Low Price ($) High Price ($) The Funds Sale 11/27/2024 10,550 14.07 13.99 14.25 The Funds In-kind Distribution 12/02/2024 10,845 (1) (2) (2) (2) The Funds Sale 12/03/2024 102,500 14.36 13.85 14.45 The Funds In-kind Distribution 12/05/2024 577,005 (1) (2) (2) (2) The Funds Sale 12/05/2024 42,000 14.03 13.98 14.06 The Funds Sale 12/06/2024 100,000 14.29 14.20 14.70 (1) Represents the number of shares distributed by the Funds to their respective members. (2) The in-kind distribution was effected for no additional consideration. (d) No other person is known to have the right to receive or the power to direct the receipt of dividends from, or any proceeds from the sale of, the shares of Stock beneficially owned by any of the Reporting Persons. (e) Not applicable.
Material to be Filed as Exhibits
Item 7. Material to be Filed as Exhibits
of the Statement is hereby amended and
Item 7 of the Statement is hereby amended and supplemented as follows: Exhibit 99.1 Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G. 6
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: December 9, 2024 Crosslink Capital, Inc. By: /s/ Maureen Offer Name: Maureen Offer Title: Chief Financial Officer Crosslink Capital Management, LLC By: /s/ Maureen Offer Name: Maureen Offer Title: Chief Financial Officer Crosslink Ventures VII Holdings, L.L.C. By: /s/ Maureen Offer Name: Maureen Offer Title: Chief Financial Officer /s/ Michael J. Stark Michael J. Stark ATTENTION Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001). 7 Exhibit(s): Exhibit 99.1 Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G.